Nitrous Oxide activates layer 5 prefrontal cortical neurons via SK2 channel inhibition for antidepressant effect
Joseph Cichon, Thomas Joseph, Andrzej Z Wasilczuk, Daniel Markman, Max B Kelz, Peter Nagele
preprint DOI: 10.21203/rs.3.rs-3706278/v1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical study |
|---|---|
| Population | Rodents exposed to chronic stress conditions |
| Intervention | Nitrous oxide |
| Key points | Nitrous oxide induces rapid and specific activation of layer V pyramidal neurons in the prefrontal cortex via inhibition of SK2 channels, which is necessary for its antidepressant action. |
Abstract
Abstract Nitrous oxide (N2O) induces rapid and durable antidepressant effects in patients suffering from treatment-resistant depression1,2. The cellular and circuit mechanisms mediating this process are not known. Here we find that a single dose of inhaled N2O induces rapid and specific activation of layer V (L5) pyramidal neurons in the prefrontal cortex of rodents exposed to chronic stress conditions. N2O-induced L5 activation rescues a stress-associated hypoactivity state, persists following N2O exposure, and is necessary for its antidepressant action. While NMDA-receptor (NMDA-R) antagonism has been N2O’s purported mechanism of action, L5 neurons activate independently from NMDA-R function and synaptic activity. By examining different molecular targets controlling excitability and cortical circuit elements, we identify N2O-induced inhibition of calcium-sensitive potassium (SK2) channels as a primary molecular interaction responsible for driving both rapid and persistent L5 activity along with its ensuing antidepressant-like effects. These results suggest that N2O-induced L5 activation is crucial for its fast antidepressant action and this effect involves novel and specific molecular actions with SK2 channels expressed in specific L5 cell types.
Citations in the library
Cites 6
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines Nature Communications June 3, 2019
- A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Science Translational Medicine June 9, 2021
- Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry Current Drug Research Reviews June 1, 2019
- Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation Science April 12, 2019
and 1 more in the library